Journal: Current Pharmaceutical Design
Guest editor(s):Dr. Sidharth Mehan

Introduction

Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and pharmaceutical companies alike. By examining the latest advancements, emerging technologies, and unresolved issues, this issue seeks to foster a deeper understanding of the complexities involved in managing neurological dysfunctions.

Keywords

Neuropharmacology, Neurological disorders, Drug delivery, Precision medicine, Biomarkers, Clinical trials, Neuroethics , Innovation